To provide non-GLP standard, initial profiling of lead compounds in rodent pharmacokinetics (PK) screening assays to provide important data for selection of the most promising lead series as well as…
Ended Awarded Last action
- Contract number
- 75N93020F00004
- Awardee
-
Eurofins Discovery Services North America, LLC UEI HF4LCAU68M93
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $207,360
Award facts
- Contract value 100% obligated
- $207,360.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- St Peters, MO 63304, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$8,640 | |
| Exercise an Option | $86,400 | |
| Original award | $129,600 |
About this award
This is a $207,360 firm fixed price delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc. to provide non-GLP standard, initial profiling of lead compounds in rodent pharmacokinetics screening assays. The work supports the selection of promising lead series and in vitro-in vivo correlation data for the development of interventional agents. This delivery order is under the NIH's Nonclinical Services for Development of Interventional Agents indefinite delivery/indefinite quantity contract vehicle. Eurofins Panlabs, Inc. is a foreign-owned for-profit contract research organization that has previously provided analytical, microbiology, and toxicology testing services to various federal agencies. The contract has no set-aside designation.
Description
To provide non-GLP standard, initial profiling of lead compounds in rodent pharmacokinetics (PK) screening assays to provide important data for selection of the most promising lead series as well as provide data for in vitro-in vivo correlation of as
Quick answers
Who was awarded contract 75N93020F00004?
75N93020F00004 was awarded to Eurofins Discovery Services North America, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 13, 2020.
How much is contract 75N93020F00004 worth?
The government has obligated $207,360 on 75N93020F00004.
Is contract 75N93020F00004 an order under another contract?
Yes. 75N93020F00004 is a delivery order under 75N93018D00007, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93020F00004 competed?
The extent of competition for 75N93020F00004 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award